{"schema_version":"1","generated_at":"2026-11-04T06:27:29.853Z","data_as_of":null,"url":"https://www.findmykol.com/kol/richard-walgren","json_url":"https://www.findmykol.com/kol/richard-walgren/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"richard-walgren","name":"Richard Walgren","credential":"MD, PhD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Eli Lilly","institution_url":"https://www.findmykol.com/institution/eli-lilly","city":"Indianapolis","state":"IN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1356437727","openalex":"A5009773917"},"summary":"Richard Walgren is an Oncology physician affiliated with Eli Lilly. OpenAlex indexes 94 publications with 3,375 citations (h-index 30).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":94,"cited_by_count":3375,"h_index":30,"latest_activity_year":2025,"source":"works"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Pirtobrutinib in Relapsed/Refractory (R/R) Waldenström macroglobulinemia (WM): Up to 5 years of follow-up from the Phase 1/2 BRUIN study","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-226","status":"verified"},{"title":"Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial","year":2024,"journal":"Haematologica","source_url":"https://doi.org/10.3324/haematol.2024.285754","status":"verified"},{"title":"Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.00562","status":"verified"},{"title":"Pirtobrutinib preclinical characterization: a highly selective, non-covalent (reversible) BTK inhibitor","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2022018674","status":"verified"},{"title":"Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: a real-world database study","year":2023,"journal":"Leukemia & lymphoma/Leukemia and lymphoma","source_url":"https://doi.org/10.1080/10428194.2023.2190436","status":"verified"}],"source":"works"},"similar":[{"name":"Mark Bangs","slug":"mark-bangs","institution":"Eli Lilly","specialty":"Child & Adolescent Psychiatry","url":"https://www.findmykol.com/kol/mark-bangs","json_url":"https://www.findmykol.com/kol/mark-bangs/profile.json"},{"name":"David Alan Cox","slug":"david-cox-us","institution":"Eli Lilly","url":"https://www.findmykol.com/kol/david-cox-us","json_url":"https://www.findmykol.com/kol/david-cox-us/profile.json"},{"name":"Mike Hutton","slug":"mike-hutton","institution":"Eli Lilly","url":"https://www.findmykol.com/kol/mike-hutton","json_url":"https://www.findmykol.com/kol/mike-hutton/profile.json"},{"name":"Yoshitaka Isaka","slug":"yoshitaka-isaka","institution":"Eli Lilly","url":"https://www.findmykol.com/kol/yoshitaka-isaka","json_url":"https://www.findmykol.com/kol/yoshitaka-isaka/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}